NFA
NXTM

Nationwide Fund Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Nationwide Fund Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-34,882
Closed -$963K – 2855
2017
Q3 		$963K Sell
34,882
-194,071
-85% -$5.18M ﹤0.01% 1812
2017
Q2 		$5.74M Sell
228,953
-30,022
-12% -$743K 0.02% 934
2017
Q1 		$6.95M Buy
258,975
+219,196
+551% +$6.06M 0.03% 838
2016
Q4 		$1.04M Sell
39,779
-1,913
-5% -$47.3K ﹤0.01% 1749
2016
Q3 		$1.04M Hold
41,692
– – ﹤0.01% 1761
2016
Q2 		$904K Buy
41,692
+968
+2% +$17.3K ﹤0.01% 1792
2016
Q1 		$626K Sell
40,724
-585
-1% -$9.8K ﹤0.01% 1971
2015
Q4 		$905K Buy
41,309
+910
+2% +$17K ﹤0.01% 1780
2015
Q3 		$637K Sell
40,399
-882
-2% -$14.1K ﹤0.01% 1961
2015
Q2 		$590K Sell
41,281
-74,645
-64% -$1.26M ﹤0.01% 2152
2015
Q1 		$2.01M Buy
115,926
+69,313
+149% +$1.22M 0.01% 1473
2014
Q4 		$836K Sell
46,613
-730
-2% -$11.8K ﹤0.01% 1901
2014
Q3 		$622K Buy
47,343
+171
+0.4% +$2.3K ﹤0.01% 2076
2014
Q2 		$678K Buy
47,172
+968
+2% +$12.6K ﹤0.01% 2091
2014
Q1 		$589K Sell
46,204
-52
-0.1% -$678 ﹤0.01% 1982
2013
Q4 		$463K Sell
46,256
-1,277
-3% -$14.5K ﹤0.01% 2278
2013
Q3 		$626K Buy
47,533
+5,581
+13% +$73.2K ﹤0.01% 2107
2013
Q2 		$599K Buy
+41,952
New +$528K ﹤0.01% 1942

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nationwide Fund Advisors's NXTM Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of NxStage Medical Inc. (NXTM) in Q4 2017, closing a stake of 34,882 shares — an estimated $963K sold.

Nationwide Fund Advisors first reported a position in NXTM in Q2 2013 and held it in 18 quarters. The position peaked at $6.95M in Q1 2017. 178 funds tracked by Wall St. Rank hold NXTM as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining NxStage Medical Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 34,882 NxStage Medical Inc. shares in Q4 2017, an estimated $963K.
  • Nationwide Fund Advisors first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's NxStage Medical Inc. position peaked at $6.95M in Q1 2017.
  • 178 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.